AzTrials
AzTrials

AphasiaNCT01602263

Transcranial Direct Current Stimulation (tDCS) and Cognitive Processing

An observational study of Aphasia and Autism, run by Johns Hopkins University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This research is being done to determine whether transcranial direct current stimulation (tDCS) can improve certain mental abilities. In this research, battery powered device is used to deliver very weak electrical current to the surface of the scalp while participants complete cognitive tasks. Read more about this study

Who is it for?
Ages 18 to 79 yearsHealthy volunteers can take part
Conditions the study is for
Aphasia, Autism, Schizophrenia
What is being tested?
Transcranial Direct Current Stimulation (tDCS)
Type of treatment
Surgery or procedure
How many people
307 participants
Where
1 siteUnited States
Study dates
Jan 2009to 2 Mar 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 79 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: You must also belong to one of three groups to join this study: 1. Healthy adults with no known deficits in cognition 2. Adults with acquired language problems (i.e., stroke, mental illness) 3. Adults with developmental language delays

Eligibility Criteria by Study Group

Normal Controls Inclusion Criteria:

  • Right handed (as determined by the Edinburgh battery)
  • English as native language

Normal Controls Exclusion Criteria:

  • Appreciable deficits in hearing
  • Appreciable problems with articulation
  • Schizophrenia, bipolar disorder, or major depression
  • Appreciable accent
  • Any neurological disorder associated with cognitive impairment or neuroanatomic abnormality
  • Language-based learning disorder
  • Any implanted metal device (precludes use of tDCS)
  • Any implanted cardiac pacemaker
  • Dementia or Mini-Mental State Exam < 24
  • Estimated verbal intelligence < 70

Aphasia Group Inclusion Criteria:

  • Right handed (as determined by the Edinburgh battery)
  • English as native language
  • History of acquired left-hemisphere dysfunction

Aphasia Group Exclusion Criteria:

  • Appreciable deficits in hearing
  • Schizophrenia, bipolar disorder, or major depression
  • Appreciable accent
  • Language-based learning disorder
  • Any implanted metal device
  • Any implanted cardiac pacemaker
  • Mini-Mental State Exam < 21/27 (omitting naming \& items)
  • Estimated verbal intelligence < 70

Schizophrenia/First-degree Family Members Inclusion Criteria:

  • Right handed (as determined by the Edinburgh battery)
  • English as native language
  • Diagnosis of schizophrenia (SZ) or bipolar disorder (BD)
  • First degree family member of individual with SZ or BD

Schizophrenia/First-degree Family Members Exclusion Criteria:

  • Appreciable deficits in hearing
  • Appreciable accent
  • Any implanted metal device (precludes use of tDCS)
  • Any implanted cardiac pacemaker
  • Dementia or Mini-Mental State Exam < 24
  • Estimated verbal intelligence < 70

High-functioning Autism Inclusion Criteria:

  • Right handed (as determined by the Edinburgh battery)
  • English as native language
  • Diagnosis of High-functioning autism (i.e., Asperger's)

High-functioning Autism Exclusion Criteria:

  • Appreciable deficits in hearing
  • Schizophrenia, bipolar disorder, or major depression
  • Appreciable accent
  • Any implanted metal device
  • Any implanted cardiac pacemaker
  • Dementia or Mini-Mental State Exam < 24
  • Estimated verbal intelligence < 70

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Department of Neurology; Cognitive Neurology/Neuropsychology

    Baltimore, Maryland, 21231

Other trials in United States

About this study

Official title: Transcranial Direct Current Stimulation (tDCS)and Cognitive Processing

This research is being done to determine whether transcranial direct current stimulation (tDCS) can improve certain mental abilities. In this research, battery powered device is used to deliver very weak electrical current to the surface of the scalp while participants complete cognitive tasks. Our aim is to find out whether tDCS will improve task performance in both healthy adults and those with neurological impairment.

Read the detailed description

Participants enrolled into this study may be asked to do the following:

  • Grant permission for the researchers to view medical records associated with their language/cognitive difficulties (if applicable.
  • Complete a questionnaire, provide a health history, and take some pencil-and-paper tests of problem-solving and memory in order to verify eligibility to participate and to able to safely undergo the experimental procedures.
  • Complete several tasks (i.e., saying words out loud, naming objects, drawing designs, remembering lists of words, searching for images or letters, and/or completing puzzles) based upon a number of cognitive functions such as language, memory, vision, processing, and perception.
  • Wear electrodes that will be placed on the scalp with a large rubberized band. These electrodes will administer very weak electrical current (tDCS) from a battery powered device for 20 to 60 minutes.
  • Participation in several study conditions. The exact conditions and their order will be randomized. Under some conditions, participants may receive active stimulation (tDCS) and under other conditions, they may receive sham stimulation.
  • The experimental sessions will last approximately 2 hours and participants may be asked to have more than one testing session in a day or to return for additional sessions.
  • Have a Magnetic Resonance Imaging (MRI) brain scan.
Being tested
Transcranial Direct Current Stimulation (tDCS)
Keywords
Normal cognitive function, Aphasia, Autism, Schizophrenia
Medical subject headings
Aphasia, Autistic Disorder, Schizophrenia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcranial Direct Current Stimulation (tDCS)Procedure or surgery

    Anodal, Cathodal or Sham tDCS.

Study groups in NCT01602263
Study groupRoleWhat they receive
ControlsHealthy Controls with no known cognitive impairment will have Transcranial Direct Current Stimulation (tDCS) administered and receive either Anodal, Cathodal or Sham tDCS.
Receives: Procedure: Transcranial Direct Current Stimulation (tDCS)
Individuals with schizophreniaIndividuals with schizophrenia and first-degree relatives will have Transcranial Direct Current Stimulation (tDCS) administered and receive either Anodal, Cathodal or Sham tDCS.
Receives: Procedure: Transcranial Direct Current Stimulation (tDCS)
Individuals with aphasiaIndividuals with aphasia will have Transcranial Direct Current Stimulation (tDCS) administered and receive either Anodal, Cathodal or Sham tDCS.
Receives: Procedure: Transcranial Direct Current Stimulation (tDCS)
Individuals with high-functioning autismIndividuals with high-functioning autism will have Transcranial Direct Current Stimulation (tDCS) administered and receive either Anodal, Cathodal or Sham tDCS.
Receives: Procedure: Transcranial Direct Current Stimulation (tDCS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Indices of cognitive function

    Measured: The average time frame is 1 hour

Secondary outcomes (2)
  1. Persistence of cognitive enhancements following tDCS

    Measured: The average time frame is 1 hour

  2. Initiation, endurance and cessation of skin sensations caused by tDCS

    The initiation, endurance and cessation of skin sensations caused by tDCS will be examined in order to develop a more effective blinding procedure.

    Measured: The average time frame is 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 May 2012 (estimated)
  2. Study startJan 2009
  3. Primary completion23 Dec 2017
  4. Study completion2 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
307 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01602263
Sponsor's protocol ID
NA_00015657
Other IDs
15657
Status last verified
Mar 2023
First submitted
14 May 2012
Last updated
7 Mar 2023
Results posted
No
Data monitoring committee
Yes

Publications

  • van Steenburgh JJ, Varvaris M, Schretlen DJ, Vannorsdall TD, Gordon B. Balanced bifrontal transcranial direct current stimulation enhances working memory in adults with high-functioning autism: a sham-controlled crossover study. Mol Autism. 2017 Jul 28;8:40. doi: 10.1186/s13229-017-0152-x. eCollection 2017.

    PubMed 28775825
  • Vannorsdall TD, van Steenburgh JJ, Schretlen DJ, Jayatillake R, Skolasky RL, Gordon B. Reproducibility of tDCS Results in a Randomized Trial: Failure to Replicate Findings of tDCS-Induced Enhancement of Verbal Fluency. Cogn Behav Neurol. 2016 Mar;29(1):11-7. doi: 10.1097/WNN.0000000000000086.

    PubMed 27008245

Questions about this trial

What is this clinical trial studying?

An observational study of Aphasia and Autism, run by Johns Hopkins University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Indices of cognitive function (time frame: The average time frame is 1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01602263, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in